Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doog- Let's hope they don't blow this deal on Gluco. Their track record in regards to closing deals is extremely poor for some reason.
And if Regabatin is really and NDA, they should close the deal now. If no deal on Regabatin in 2018, I don't believe it is actually an NDA candidate but possibly an ANDA 10 years down the road...
Somebody needs to wake IPCI up and let them know that opportunity is passing them by. And if they choose dilution over deal right now, they are throwing every long term shareholder under the bus!
Thanks for sending Fabius. The leaked information shorts get has to be coming from proactive or the scumbags doing the offerings.
doog- I agree that Smith guy and the NY firm is a joke. They deserve nothing. I am guessing he is their connection to Roth and Wainwright- in other words, when they need money they call him. That is part of the reason why they get manipulated so easily. This NY IR firm, Wainwright, Roth, etc. all are privy to inside info prior to it becoming public. That is why the shorts always know and have plenty of time to cover. They are in with these guys.
Impact- I want you to know I have demanded action out of them. I am hoping others will as well.
Impact- I have been emailing both Odidi and Patient telling them they cannot dilute at these levels. I hope you have been giving them an earful too. I hope other shareholders will so the same. It will make my scathing emails resonate with them hopefully. If you own shares in this company, you cannot sit idly without contacting these guys. I know they always read them but you will noy always get a reply.
Doog- The problem is someone at IPCI always blocks the deals from going through. I urge all shareholders to write Odidi and Patient and tell them that they cannot dilute at these levels and they need to start taking the deals.
BTJ- I really wish I believed that you were right. But I now feel the shorts are being fed info by Roth, Wainwright- guys that do the offerings. Any type of good news will be given to them in advance. And they will have plenty of time to cover.
blue- here is Patient's email: APatient@intellipharmaceutics.com
Make sure you let him know you are a shareholder and that their performance sucks!
Impact, you are right. I have watched the action. They are walking it down by trading to themselves. They will not touch real orders and wash trade just fractions of a cent above the order. Once the real order is filled they start trading lower than the real order. I have watched this time and time again when trying to get filled.
Everyone- Make sure you send an email or call Patient and Odidi and let them know an offering at these levels is unacceptable and will be the end of the company.
The Seroquel sales thus far are a huge disappointment. I just cannot fathom how they are this low... I was expecting about $1M per month in revenue for IPCI. The analysts were projecting like $2-3M per month in revenue. So far a disaster.
Cironman- Wainwright issuing an upgrade is a reliable sign that they want to do an offering for a customer.
wimike, fabius and all- I agree that the company needs to figure out a way to fund the company other than a dilutive raise. At these levels, another raise would be devastating. I hope they understand the urgency of this matter. They need to start signing some deals NOW!
Fabius- I am hoping Chinese contract manufacturing partnership is close. I think that will first involve Gluco and maybe Keppra. I think Seroquel and other generics will certainly follow. It just makes sense to manufacture Generics in a low cost environment...
I have done some looking into the Chinese deal. I think I have good idea what is going on. The latest info only gives a few lines, but I think it tells all. Here are my opinions:
1. Smart Pharma will have no involvement with IPCI. It appears they may be in the market of creating/ selling drugs for specific ailments/conditions in Africa. These types of products have nothing to do with IPCI's core business of controlled release drugs. Dr. Odidi may or may not have some involvement with this company. But it does not matter as they are not a competitor to IPCI.
2. Partnerships. I believe IPCI is looking for various manufacturing and possibly marketing partners in China. I believe an Obvious one is Shanghai Yunfeng Pharmaceuticals. I believe this company would be a good fit to manufacture Gluco and Keppra at the pricepoint it need to be manufactured to compete. Could be other companies they are looking into, but this is one they obviously have ties to, so you figure it out...
3. Contract manufacturing. Same as number 2. They are looking for someone to manufacture generics at low cost for all markets. I believe this is Shanghai Yunfeng.
4. Raw Materials Sourcing. IPCI has also been looking for lower cost sources for raw materials in China. I believe first intent is to get these materials shipped to Toronto. So that they can produce, Seroquel, etc. for lower costs. I am guessing this source for raw materials is Shanghai Yunfeng source. But don't be surprised if when they partner with Shanghai Yunfeng that Seroquel production also moves to China. One again at Shanghai Yunfeng Pharmaceuticals.
That pretty much sums up my opinions...
Good luck Doog
Swe77- Yes- looks like Seroquel split is high. However, the problem we are seeing no sales.
Doog- Q4 revenues were just under $1.1M. It also says in 2017 $700K for Seroquel cost of goods sold.
It appears they have someone interested in Regabatin. I really hope they can finally close the partnership deal and commence PH3 studies on this.
Sprot- They gave a concise, clear timeline on what they plan to do this year. Late 2018 we can review. I think it will be clear whether they delivered as promised or failed.
Doog- Management put out a timeline for what they plan to accomplish. If they do all of that or even 75% of it, things will be good. In a phone conversation with IPCI, I let them know I was disappointed that they did not hit the deadline for starting the HAP tests. The response was they were only a few days late and the FDA has not approved protocol. I said that's fine but over the last several years IPCI has not delivered and delayed and made excuses.... So I see putting out that timeline as a very bold statement that we will accomplish all these things in 2018. I know if they do not, I plan to call them out personally. That being said, I do get the impression they really may deliver this time.
Sure seems to me whenever I hear the name sabby it's always in relation to short selling. Wondering if they were offering buyer? Wondering also if they short sold in advance of offering...
Blue- Hypothetically what you are saying:
1. 2 to 1 reverse split. 34M shares down to 17M shares. Price $0.75 to $1.50.
2. Offering to sell 8M shares @ $1.50 for a total of $12M and net company roughly $10M.
That type of deal will be selling roughly 1/3 of the company equity to net $10M. And thats a best case scenario...
Now I am guessing Dr. Odidi won't want to go down that road... If he does he will certainly lose control of the company. So, the good Dr. better have some better plans up his sleeve or his baby slips away...
Impact bashing on stocktwits, so does that mean we go up?
mopar- yeah they don't do it near enough...
Very low volume today. Looks like MM has backed off on the selling and wash trading. Probably just holding pat until earnings/CC is over and then will decide how to proceed.
I will be on the call listening. May or may not ask a question.
Tilator - I am with you. That was done to gain final fda approvals... Like you said to get final approval packaging, etc. Needs to be approved.
Numbers- So did IPCI ever sell any? Did they even try? Or were those maybe part of some FDA site inspection or the like?
Doog- I can hear them calling in the sheep right now... LOL
wimike- Yes and his ratings is 0 stars! People have been making money in the market hand over fist since 2010... And this guy is negative. He is not Joe Schmoe on Twitter either... He is a professional analyst. I can just see his boss. You get to cover IPCI. We want to broker their next offering. So give them a BUY rating. LOL.
Everybody get ready for a run... O star ranked analyst from Wainwright said IPCI is going to recover. LOL.
http://www.analystratings.com/articles/h-c-wainwright-thinks-intellipharmaceutics-internationals-stock-is-going-to-recover/
Fabius- I think shorts are as follows:
1. MM- probably the biggest player and not borrowing shares. Constantly wash trading and shorting, driving down and covering.
2. Offering buyers- These guys probably hold most of the shares short. Probably some gaming but some may just be using as a hedge.
3. Small time players- These are the gamers that are borrowing. Probably the idiots on here and Stocktwits. Just riding coat tails of MM and some are doing for maybe 100K while others are just 10K or a several 10K.
Beach- The short covering occurred on the day the China news leaked. When many million shares were traded/wash traded and price went to about $1. They had to wash trade almost 10 million shares to cover a couple hundred thousand... Don't tell me that isn't the MM who was covering a naked short. Because it likely was. So on that day, I am guessing whoever had borrowed some shares covered too. Then when things became partially clear on Monday that no deal was coming. I am guess these guys started short selling again.
Samsa- you are 100% right in your assessment of what Perdue is doing.
Junkie- In my opinion, this latest development by Perdue is due to all the litigation. The info just said they will not promote opiods to Drs. My guess is they will continue to sell as much opiod product as they can but they will no longer be wining and dining Drs out in the open. this is nothing more than a legal ploy in the face of all the litigation.
Beach- shorts always know ahead of retail investors. Because shorts are not retail investors. I think ipci shorts are same people that buy offerings as well as mms.
https://www.yahoo.com/news/house-senate-pursue-spending-deals-052307098.html
See below... Funding to combat opioid abuse:
WASHINGTON (AP) -- The Senate's top leaders announced Wednesday they have sealed agreement on a two-year budget pact that would shower both the Pentagon and domestic programs with almost $300 billion above existing limits, giving wins to both GOP defense hawks and Democrats seeking billions for infrastructure projects and combatting opioid abuse.
The agreement is likely to be added to a stopgap spending bill that passed the House on Tuesday and is aimed at averting a government shutdown Thursday at midnight.
The plan also contains almost $90 billion in overdue disaster aid for hurricane-slammed Texas, Florida and Puerto Rico.
And it would increase the government's borrowing cap to prevent a first-ever default on U.S. obligations that looms in just a few weeks.
The House's top Democrat, however, swung out against the plan.
House Minority Leader Nancy Pelosi of California announced she would oppose the budget measure unless her chamber's GOP leaders promised a vote on legislation to protect "Dreamer" immigrants who face deportation after being brought to the U.S. illegally as children.
The House on Tuesday passed legislation to keep the government running through March 23, marrying the stopgap spending measure with a $659 billion Pentagon spending plan, but the Senate plan would rewrite that measure.
Senate Democratic leaders have dropped their strategy of using the funding fight to extract concessions on immigration, specifically on seeking extended protections for the "Dreamer" immigrants. Instead, Senate Minority Leader Chuck Schumer, D-N.Y., went with a deal that would reap tens of billions of dollars for other priorities — including combatting opioids — while hoping to solve the immigration impasse later.
The budget agreement would give both the Pentagon and domestic agencies relief from a budget freeze that lawmakers say threatens military readiness and training as well as domestic priorities such as combating opioid abuse and repairing the troubled health care system for veterans.
Doog- Yes, everyone post their questions and we can send them to IPCI in advance.
Doog- The manufacturing facility is Shanghai Yungfeng- an already established company. I don't think Odidi started much of anything. I am guessing just some consulting on getting their facilities ready to manufacture the generics for IPCI. And yes he does really need to start disclosing the details of the relationship.